Trial Profile
An exploratory, randomized, double blind, placebo controlled, parallel groups Phase II clinical trial to evaluate the efficacy and safety of E-52862 (400 mg) by oral route, in patients with painful diabetic neuropathy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Nov 2016
Price :
$35
*
At a glance
- Drugs E 52862 (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Proof of concept; Therapeutic Use
- Sponsors Laboratorios Dr. Esteve
- 30 Sep 2016 Results of this study, presented at the 16th World Congress on Pain.
- 07 Feb 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
- 06 Jul 2012 New trial record